Both in Biotechnology
Solid Biosciences vs Ginkgo Bioworks Holdings
Over the past year SLDB returned +24.3% and DNA returned −12.9%; their daily moves had a correlation of 0.29.
SLDB +24.3% DNA −12.9%Growth of $1, one year, split-adjusted
| Metric | SLDB | DNA |
|---|---|---|
| Price | $6.47 | $11.15 |
| Market cap | $693.2M | $750.5M |
| Today | +2.95% | +3.58% |
| 1 month | −6.6% | −10.2% |
| 6 months | −10.2% | +10.6% |
| Year to date | +14.6% | +34.1% |
| 1 year | +24.3% | −12.9% |
| Revenue growth (YoY) | — | −48.5% |
| Gross margin | — | 91.5% |
| Net margin | — | −231.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.7× |
| Net cash | $377.7M | $302.2M |
| Dividend yield | — | — |
| Volatility (60d) | 68.2% | 128.2% |
| Short % of float | 17.8% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).